Literature DB >> 19802855

3,5-Bis(benzylidene)-4-oxo-1-phosphonopiperidines and related diethyl esters: Potent cytotoxins with multi-drug-resistance reverting properties.

Swagatika Das1, Umashankar Das, Ponniah Selvakumar, Rajendra K Sharma, Jan Balzarini, Erik De Clercq, Joseph Molnár, Julianna Serly, Zoltán Baráth, Gabriele Schatte, Brian Bandy, Dennis K J Gorecki, Jonathan R Dimmock.   

Abstract

A series of 3,5-bis(benzylidene)-4-piperidones 3 were converted into the corresponding 3,5-bis(benzylidene)-1-phosphono-4-piperidones 5 via diethyl esters 4. The analogues in series 4 and 5 displayed marked growth inhibitory properties toward human Molt 4/C8 and CEM T-lymphocytes as well as murine leukemia L1210 cells. In general, the N-phosphono compounds 5, which are more hydrophilic than the analogues in series 3 and 4, were the most potent cluster of cytotoxins, and, in particular, 3,5-bis-(2-nitrobenzylidene)-1-phosphono-4-piperidone 5 g had an average IC(50) value of 34 nM toward the two T-lymphocyte cell lines. Four of the compounds displayed potent cytotoxicity toward a panel of nearly 60 human tumor cell lines, and nanomolar IC(50) values were observed in a number of cases. The mode of action of 5 g includes the induction of apoptosis and inhibition of cellular respiration. Most of the members of series 4 as well as several analogues in series 5 are potent multi-drug resistance (MDR) reverting compounds. Various correlations were noted between certain molecular features of series 4 and 5 and cytotoxic properties, affording some guidelines in expanding this study.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19802855      PMCID: PMC3346747          DOI: 10.1002/cmdc.200900288

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  21 in total

1.  3,5-Bis-benzylidene-4-piperidones and related compounds with high activity towards P388 leukemia cells.

Authors:  J R Dimmock; V K Arora; S L Wonko; N W Hamon; J W Quail; Z Jia; R C Warrington; W D Fang; J S Lee
Journal:  Drug Des Deliv       Date:  1990-09

2.  Coumarin derivatives with tumor-specific cytotoxicity and multidrug resistance reversal activity.

Authors:  Masami Kawase; Hiroshi Sakagami; Noboru Motohashi; Hermann Hauer; Shyam S Chatterjee; Gabriella Spengler; Aniko Varadi Vigyikanne; Annamaria Molnár; Joseph Molnár
Journal:  In Vivo       Date:  2005 Jul-Aug       Impact factor: 2.155

3.  Chemosensitization by buthionine sulfoximine in vivo.

Authors:  K Tsutsui; C Komuro; K Ono; T Nishidai; Y Shibamoto; M Takahashi; M Abe
Journal:  Int J Radiat Oncol Biol Phys       Date:  1986-07       Impact factor: 7.038

4.  Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing.

Authors:  J Carmichael; W G DeGraff; A F Gazdar; J D Minna; J B Mitchell
Journal:  Cancer Res       Date:  1987-02-15       Impact factor: 12.701

5.  A conformational and structure-activity relationship study of cytotoxic 3,5-bis(arylidene)-4-piperidones and related N-acryloyl analogues.

Authors:  J R Dimmock; M P Padmanilayam; R N Puthucode; A J Nazarali; N L Motaganahalli; G A Zello; J W Quail; E O Oloo; H B Kraatz; J S Prisciak; T M Allen; C L Santos; J Balzarini; E De Clercq; E K Manavathu
Journal:  J Med Chem       Date:  2001-02-15       Impact factor: 7.446

Review 6.  1,5-diaryl-3-oxo-1,4-pentadienes: a case for antineoplastics with multiple targets.

Authors:  U Das; R K Sharma; J R Dimmock
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

7.  c-Yes tyrosine kinase activity in human colon carcinoma.

Authors:  J Park; A I Meisler; C A Cartwright
Journal:  Oncogene       Date:  1993-10       Impact factor: 9.867

8.  Role of cellular glutathione and glutathione S-transferase in the expression of alkylating agent cytotoxicity in human breast cancer cells.

Authors:  G Chen; D J Waxman
Journal:  Biochem Pharmacol       Date:  1994-03-15       Impact factor: 5.858

9.  Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells.

Authors:  J M Zamora; H L Pearce; W T Beck
Journal:  Mol Pharmacol       Date:  1988-04       Impact factor: 4.436

Review 10.  The National Cancer Institute: cancer drug discovery and development program.

Authors:  M R Grever; S A Schepartz; B A Chabner
Journal:  Semin Oncol       Date:  1992-12       Impact factor: 4.929

View more
  8 in total

1.  Tumor-selective cytotoxicity of a novel pentadiene analogue on human leukemia/ lymphoma cells.

Authors:  Yahaira Santiago-Vázquez; Umashankar Das; Armando Varela-Ramirez; Sarah T Baca; Yoshira Ayala-Marin; Carolina Lema; Swagatika Das; Alaa Baryyan; Jonathan R Dimmock; Renato J Aguilera
Journal:  Clin Cancer Drugs       Date:  2016

2.  A general HPLC-UV method for the quantitative determination of curcumin analogues containing the 1,5-diaryl-3-oxo-1,4-pentadienyl pharmacophore in rat biomatrices.

Authors:  Ravi Shankar Prasad Singh; Umashankar Das; Jonathan R Dimmock; Jane Alcorn
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2010-09-20       Impact factor: 3.205

3.  Bis[3,5-bis(benzylidene)-4-oxo-1-piperidinyl]amides: a novel class of potent cytotoxins.

Authors:  Swagatika Das; Umashankar Das; Armando Varela-Ramírez; Carolina Lema; Renato J Aguilera; Jan Balzarini; Erik De Clercq; Stephen G Dimmock; Dennis K J Gorecki; Jonathan R Dimmock
Journal:  ChemMedChem       Date:  2011-08-08       Impact factor: 3.466

4.  Sequential cytotoxicity: a theory examined using a series of 3,5-bis(benzylidene)-1-diethylphosphono-4-oxopiperidines and related phosphonic acids.

Authors:  Swagatika Das; Umashankar Das; Hiroshi Sakagami; Ken Hashimoto; Masami Kawase; Dennis K J Gorecki; Jonathan R Dimmock
Journal:  Bioorg Med Chem Lett       Date:  2010-09-17       Impact factor: 2.823

5.  CLEFMA-an anti-proliferative curcuminoid from structure-activity relationship studies on 3,5-bis(benzylidene)-4-piperidones.

Authors:  Pallavi Lagisetty; Prachi Vilekar; Kaustuv Sahoo; Shrikant Anant; Vibhudutta Awasthi
Journal:  Bioorg Med Chem       Date:  2010-06-22       Impact factor: 3.641

6.  1-Benzyl-3,5-bis-(4-methyl-benzyl-idene)-4-oxopiperidin-1-ium chloride acetic acid monosolvate.

Authors:  Ju-Feng Sun; Juan Xing; Jing-Tian Han
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-05-07

7.  Bis[5-meth-oxy-2-(meth-oxy-carbon-yl)phen-yl] methyl-phospho-nate.

Authors:  Saghir Hussain; Yang Deli; Shagufta Parveen; Xin Hao; Changjin Zhu
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2014-02-12

Review 8.  Multicomponent reactions: A simple and efficient route to heterocyclic phosphonates.

Authors:  Mohammad Haji
Journal:  Beilstein J Org Chem       Date:  2016-06-21       Impact factor: 2.883

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.